Skip to main content
IRS-authorized e-file provider · not the IRS

Nonprofit · EIN 20-5776861

CHOLANGIOCARCINOMA FOUNDATION

Tax-exempt · SALT LAKE CITY, UT 84096

Financials

$6.9M$6.2M2023$7.1M$7.2M2024
Revenue Expenses · by fiscal year end
Financials of CHOLANGIOCARCINOMA FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
June 30, 2025990$7,130,406$7,195,778-$65,372$5,767,836$1,220,153$4,547,683
June 30, 2024990$6,918,626$6,237,924$680,702$5,980,953$1,498,168$4,482,785
Financial details: 990 for the year ended June 30, 2025

Revenue

Contributions, gifts and grants
$6,634,735
Program service revenue
$357,617
Investment income
$143,869
Net gain from sales of assets
$10,536
Net income from sales of inventory
-$14,815
Other revenue
-$5,815

Expenses

Grants and similar amounts paid
$1,015,000
Compensation of officers, directors and key employees
$347,706
Other salaries and wages
$2,687,512
Salaries, compensation and benefits (total)
$3,515,927
Professional fundraising fees
$0
Legal fees
$523
Accounting fees
$11,100
Occupancy
$53,915
Travel
$535,149
Depreciation
$44,684
Program services (functional)
$5,376,715
Management and general (functional)
$492,993
Fundraising (functional)
$1,326,070

Balance sheet and other

Total assets, start of year
$5,980,953
Total assets, end of year
$5,767,836
Total liabilities, end of year
$1,220,153
Net assets, end of year
$4,547,683
Land, buildings and equipment
$62,483
Publicly traded securities
$1,671,892
Net assets without donor restrictions
$2,444,157
Net assets with donor restrictions
$2,103,526
Gross receipts
$7,229,349
Employees
32
Volunteers
250
Year formed
2006
State of legal domicile
UT

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended June 30, 2025, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
JUAN VALLECHIEF MEDICA
Highest-paid employee
40$227,510$15,529
STACIE LINDSEYCEO/FOUNDER
Trustee or director, Officer
40$178,524$7,884
ALLI WARDCOO
Former
40$143,957$3,624
MELINDA BACHINICPO
Highest-paid employee
40$132,967$6,063
LILY ZHANGCFO
Officer
40$56,219$4,463
TERESA DELCORSO-ELLMANNCHAIR
Trustee or director, Officer
5$0$0
DANIEL BLUMTREASURER
Trustee or director, Officer
2.5$0$0
ROSS GREENBOARD MEMBER
Trustee or director
2.5$0$0
JASON SCOTTBOARD MEMBER
Trustee or director
2.5$0$0
JACK CALLAWAYBOARD MEMBER
Trustee or director
2.5$0$0
LIZ WARNERBOARD MEMBER
Trustee or director
2.5$0$0
TYLER BRIDEGANBOARD MEMBER
Trustee or director
2.5$0$0
KRIS HIGHBOARD MEMBER
Trustee or director
2.5$0$0
JERRY HUANGBOARD MEMBER
Trustee or director
2.5$0$0
990 for the year ended June 30, 2024: 14 people
NameTitleHours / weekCompensationOther / benefits
STACIE LINDSEYCEO/FOUNDER
Trustee or director, Officer
40$201,774$8,714
KOURTNEY SANCHEZCDO
Highest-paid employee
40$149,512$12,047
ALLI WARDCOO
Officer
40$153,214$7,970
MELINDA BACHINICPO
Highest-paid employee
40$103,192$4,108
TERESA DELCORSO-ELLMANNCHAIR
Trustee or director, Officer
5$0$0
PATRICIA MAXINSECRETARY
Trustee or director, Officer
2.5$0$0
DANIEL BLUMTREASURER
Trustee or director, Officer
2.5$0$0
DEAN MEYERBOARD MEMBER
Trustee or director
5$0$0
ROSS GREENBOARD MEMBER
Trustee or director
2.5$0$0
JASON SCOTTBOARD MEMBER
Trustee or director
2.5$0$0
JACK CALLAWAYBOARD MEMBER
Trustee or director
2.5$0$0
LIZ WARNERBOARD MEMBER
Trustee or director
2.5$0$0
TYLER BRIDEGANBOARD MEMBER
Trustee or director
2.5$0$0
COLLEEN MATHERBOARD MEMBER
Trustee or director
2.5$0$0

Address and contacts

Address (IRS master file)
5526 WEST 13400 SOUTH STE 510, SALT LAKE CITY, UT 84096-6919
In care of
% STACIE LINDSEY
Principal officer (990 for 2024)
STACIE LINDSEY, 5526 WEST 13400 SOUTH STE 510, SALT LAKE CITY, UT 84096
Signed the 990
LILY ZHANG, CFO
Phone
(888) 936-6731
Return prepared by
BOUNTIFUL PEAK ADVISORS

Mission

THE ORGANIZATION'S MISSION IS TO FIND A CURE AND IMPROVE THE QUALITY OF LIFE FOR CHOLANGIOCARCINOMA PATIENTS.

990 for the year ended June 30, 2025

Program accomplishments

  • RESEARCH THE ORGANIZATION ADVANCES SCIENTIFIC DISCOVERY THROUGH ITS RESEARCH FELLOWSHIP PROGRAM, CAREER DEVELOPMENT AWARD, AND INNOVATION GRANTS, WHICH COLLECTIVELY SUPPORT EMERGING INVESTIGATORS AND FUND TRANSFORMATIVE, HIGH- IMPACT STUDIES. IT ALSO CONVENED THE INTERNATIONAL CHOLANGIOCARCINOMA CONSENSUS CONFERENCE, UNITING GLOBAL EXPERTS TO ESTABLISH RESEARCH PRIORITIES AND ACCELERATE CLINICAL TRANSLATION. THESE EFFORTS ARE ANCHORED IN THE INTERNATIONAL CHOLANGIOCARCINOMA RESEARCH NETWORK (ICRN) - A WORLDWIDE COLLABORATION DRIVING PROGRESS IN ETIOLOGY, PREVENTION, EARLY DETECTION, AND TREATMENT. THROUGH ICRN SUBCOMMITTEES, THE ORGANIZATION LEVERAGES SHARED DATA AND CULTIVATES FUTURE LEADERS IN RESEARCH AND CARE.
    Expenses $1,972,638 · grants $1,010,000
  • PATIENT SUPPORT THE ORGANIZATION PROVIDES SUPPORT SERVICES TO INDIVIDUALS DIAGNOSED WITH CHOLANGIOCARCINOMA AND THEIR CAREGIVERS. THESE SERVICES INCLUDE ACCESS TO A NETWORK OF PATIENT ADVOCATES, PEER MENTORS, SUPPORT GROUPS, EDUCATIONAL WEBINARS, AND DISEASE-SPECIFIC INFORMATIONAL RESOURCES. THE GOAL OF THESE PROGRAMS IS TO IMPROVE QUALITY OF LIFE BY OFFERING RELIABLE INFORMATION, EMOTIONAL SUPPORT, AND GUIDANCE TO HELP PATIENTS AND FAMILIES NAVIGATE THEIR CARE IN COORDINATION WITH HEALTHCARE PROVIDERS
    Expenses $3,404,077 · grants $5,000 · revenue $357,617

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025June 30, 2026November 16, 2026Not due yet
2024June 30, 2025November 17, 2025990 on file
2023June 30, 2024November 15, 2024990 on file

IRS record

EIN
20-5776861
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2007
Accounting year ends
June
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H99)
Assets (IRS master file)
$5,767,836
Income (IRS master file)
$7,229,349

Filing history

FormYear endedRevenueExpensesAssetsReturn
990June 2025$7,130,406$7,195,778$5,767,836XML
990June 2024$6,918,626$6,237,924$5,980,953XML
990June 2023$5,082,650$5,266,027$4,624,165IRS
990June 2022$4,935,665$3,620,452$4,018,118IRS
990June 2021–––IRS
990June 2020–––IRS
990June 2019–––IRS
990June 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-5776861).

Questions about CHOLANGIOCARCINOMA FOUNDATION

What is the EIN of CHOLANGIOCARCINOMA FOUNDATION?
The employer identification number (EIN) of CHOLANGIOCARCINOMA FOUNDATION is 20-5776861.
Is CHOLANGIOCARCINOMA FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2007.
Are donations to CHOLANGIOCARCINOMA FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does CHOLANGIOCARCINOMA FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of CHOLANGIOCARCINOMA FOUNDATION due?
The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did CHOLANGIOCARCINOMA FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended June 2025.
Who is the principal officer of CHOLANGIOCARCINOMA FOUNDATION?
The 990 for the year ended June 30, 2025 names STACIE LINDSEY.
Who are the officers and directors of CHOLANGIOCARCINOMA FOUNDATION?
The 990 for the year ended June 30, 2025 lists 14 people; 5 received compensation from the organization, the highest $227,510 (JUAN VALLE, CHIEF MEDICA).
How much revenue does CHOLANGIOCARCINOMA FOUNDATION have?
On its 990 for the year ended June 30, 2025 it reported revenue of $7,130,406, expenses of $7,195,778 and total assets of $5,767,836 at year end.

Other nonprofits in SALT LAKE CITY

All nonprofits in SALT LAKE CITY · Utah · Medical research